ZBNA
UTHR icon

Zions Bancorporation, National Association’s United Therapeutics UTHR Stock Holding History

Zions Bancorporation, National Association’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.3K Buy
54
+6
+13% +$3.38K ﹤0.01% 676
2026
Q1 		$28.5K Buy
48
+13
+37% +$6.47K ﹤0.01% 651
2025
Q4 		$17.1K Buy
35
+29
+483% +$13.5K ﹤0.01% 750
2025
Q3 		$2.52K Hold
6
– – ﹤0.01% 790
2025
Q2 		$1.72K Hold
6
– – ﹤0.01% 814
2025
Q1 		$1.85K Buy
+6
New +$2.06K ﹤0.01% 814

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Zions Bancorporation, National Association's UTHR Position: Q2 2026 in Review

Zions Bancorporation, National Association increased its United Therapeutics (UTHR) stake by 13% in Q2 2026, buying an estimated $3.38K and bringing the position to 54 shares worth $29.3K. The position accounts for ﹤0.01% of the portfolio, ranked #676.

Zions Bancorporation, National Association first reported a position in UTHR in Q1 2025 and has held it in 6 quarters since. 882 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Zions Bancorporation, National Association held 54 shares of United Therapeutics worth $29.3K as of Q2 2026.
  • Zions Bancorporation, National Association bought 6 United Therapeutics shares in Q2 2026, an estimated $3.38K.
  • United Therapeutics made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #676 holding.
  • Zions Bancorporation, National Association first reported a position in United Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 882 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.